Project: Procedures allowing medical implant manufacturers to demonstrate compliance with MRI safety regulations
Acronym | 17IND01 MIMAS (Reference Number: 17IND01) |
Duration | 01/06/2018 - 31/05/2021 |
Project Topic | In the EU alone, the market for medical implants is worth 3 billion Euros. Of the 50 million European citizens carrying such devices, the majority will at some point receive an MRI scan (Magnetic Resonance Imaging). Due to MRI magnetic field and radio wave interactions with some implants, product compatibility is a key consideration for patient safety. Scanning interference hazards could be further reduced with updated regulations, and currently time-consuming compliance testing methods discourage manufacturers from creating new products for the implant market.This project will develop the test methods needed to demonstrate implant compatibility with MRI scanning for improved patient safety. By improving models of human subjects with implants, and validation of computer modelling by comparison with test implant measurements, the project results will feed into new and existing international standards for MRI safety regulations. With an additional, simpler compliance-checking process for small implants (< 10 cm), many European manufacturers will benefit from the outcomes of this project. |
Website | visit project website |
Network | EMPIR |
Call | EMPIR Call 2017 |
Project partner
Number | Name | Role | Country |
---|---|---|---|
1 | Physikalisch-Technische Bundesanstalt | Coordinator | Germany |
2 | Istituto Nazionale di Ricerca Metrologica | Partner | Italy |
3 | NPL Management Limited | Partner | United Kingdom |
4 | Istituto Ortopedico Rizzoli | Partner | Italy |
5 | ZMT Zurich MedTech AG | Partner | Switzerland |